Deepull Diagnostics S.L.

https://www.deepull.com

LinkedIn: https://www.linkedin.com/company/deepull

deepull is a medical diagnostics company developing culture-free diagnostic solutions for sepsis and acute infections. Founded in 2020 in Barcelona by the founders of STAT-Dx (sold to QIAGEN in 2018), deepull has assembled a team of world-class experts to create rapid and accessible diagnostic solutions. Visit www.deepull.com for more and follow us on LinkedIn. deepull is developing a 1 hour, direct-from-blood PCR test targeting 95% of sepsis-causing pathogens. The test will extract total microbial DNA from 8 mL of whole blood and include 50 reportable results. The test runs on the deepull UllCORE instrument; a benchtop system with sample-to-result automation being designed to meet the needs of any hospital clinical laboratory. *

	Start	2020-06-25 established
	Industry	molecular diagnostics
	Person	Casado, Pilar (Ikon Partner 202404 Founding Partner + Deepull Diagnostics CFO +Ona Therapeutics CFO)

	Region	Barcelona
	Country	Spain (España)
	Street	4-8 C/ Baldiri Reixac
	City	08028 Barcelona
	Tel	+34-93-655-3530
		Address record changed: 2024-05-07

Basic data	Employees	n. a.

		* Document for »About Section«: Deepull Diagnostics S.L.. (4/25/24). "Press Release: Deepull Unveils 1 Hour, Direct-from-Blood Multiplex PCR Test for 95% of Sepsis-causing Pathogens at ESCMID 2024". Barcelona.

		Record changed: 2025-03-16

Picture EBD Group BIO-Europe 2025 Wien Vienna to 17 Oct 650x200px

More documents for Deepull Diagnostics S.L.

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com